论文部分内容阅读
目的探讨紫杉醇联合卡铂放疗对肿瘤患者肿瘤增生及生存质量变化的影响。方法本院2015年1月至2017年1月收治的168例肿瘤患者作为研究对象,随机分为观察组和对照组,每组各84例,对照组实施单纯放疗,观察组在放疗基础上实施联合化疗,所有患者均处于肿瘤发病中期,经过3周的放射治疗,对比观察2组患者的细胞毒性反应及患者生存治疗变化。结果经过3周放射治疗,实施紫杉醇联合卡铂放疗可以有效降低白细胞数量,观察组患者的肿瘤细胞水平明显低于对照组(P<0.05);观察组患者病情缓解及满意度调查均显著优于对照组(P<0.05)。结论实施放疗+卡铂加紫杉醇联合化疗比传统放疗方法效果更加明显,对改善患者病情提升患者信心具有重要作用。
Objective To investigate the effects of paclitaxel combined with carboplatin on tumor growth and quality of life in cancer patients. Methods A total of 168 patients with cancer treated in our hospital from January 2015 to January 2017 were randomly divided into observation group (n = 84) and control group (n = 84). The control group received radiotherapy alone and the observation group was performed on the basis of radiotherapy Combined chemotherapy, all patients were in the midst of tumor development, after 3 weeks of radiotherapy, compared the two groups of patients observed cytotoxicity and survival changes in patients. Results After 3 weeks of radiotherapy, the combination of paclitaxel and carboplatin was effective in reducing the number of leukocytes, and the tumor cells in the observation group were significantly lower than those in the control group (P <0.05). The patients in the observation group were significantly better than those in the control group Control group (P <0.05). Conclusion The combination of radiotherapy and carboplatin plus paclitaxel combined with chemotherapy is more effective than traditional radiotherapy and plays an important role in improving the patient’s condition and enhancing the patient’s confidence.